Outcomes of the Intradural Extramedullary Tumors Resection

Spinal Cord Tumor Clinical Trial

Official title:

Professor of Neurosurgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04331431
• Other study ID #: Sohag77
• Status: Completed
• Phase: N/A
• Start date: April 1, 2008
• Est. completion date: April 8, 2015

Study information

• Verified date: March 2020
• Source: Sohag University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The intradural extramedullary tumors remain curable diseases. Our aim in this study is to evaluate the postoperative status after the tumor resection and compare it to the preoperative status

Description:

Meticulous microscopic excision without nerve root or dural injuries

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: April 8, 2015
• Est. primary completion date: April 1, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 28 Years to 66 Years

Eligibility

Inclusion Criteria:

• neurological deficit

• back pain

Exclusion Criteria:

• old age above 80 years

• immunocompromised patients

Related Conditions & MeSH terms

• Spinal Cord Neoplasms
• Spinal Cord Tumor

Intervention

Procedure:
• Spinal cord tumor resection
Excision of intradural tumors

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	complete excision	delicate dissection	7 years